ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
3.90
0.10
( 2.63% )
Actualizado: 02:18:36

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
3.90
Postura de Compra
3.80
Postura de Venta
4.00
Volume Operado de la Acción
529,266
3.80 Rango del Día 3.90
3.50 Rango de 52 semanas 7.25
Capitalización de Mercado [m]
Precio Anterior
3.80
Precio de Apertura
3.80
Última hora de negociación
03:01:52
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
404,273
Acciones en circulación
533,352,523
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-3.20
Beneficio por acción (BPA)
-0.01
turnover
3.19M
Beneficio neto
-6.49M

Acerca de Eden Research Plc

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sede
Oxfordshire, Gbr
Fundado
-
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 3.80p. Over the last year, Eden Research shares have traded in a share price range of 3.50p to 7.25p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £20.27 million. Eden Research has a price to earnings ratio (PE ratio) of -3.20.

EDEN Últimas noticias

Eden Research plc Trading Update

Eden Research plc 07 November 2024   The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market...

Eden Research plc Ecovelex Approval in Italy

Eden Research plc 07 November 2024   As the information in this release pertains to EDEN RESEARCH PLC, this announcement is deemed to constitute inside information as stipulated under the...

Eden Research plc OTCQB exchange update

Eden Research plc 08 October 2024   8 October 2024     Eden Research Plc ("Eden" or "Company")     OTCQB exchange update   Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide...

Eden Research half-year revenue surges nearly 75% despite rising costs

Eden Research PLC on Monday said its half-year revenue has jumped nearly 75% higher than last year as sales grow, des ...

Eden Research plc Half yearly Report

Eden Research plc 23 September 2024     The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the...

Eden Research plc Notice of Results

Eden Research plc 20 September 2024   20 September 2024     Eden Research Plc ("Eden" or "Company")   Notice of Results   Eden Research plc (AIM:EDEN), a leader in sustainable biopesticide...

Eden Research plc Nematicide Approval in Greece

Eden Research plc 02 September 2024   2 September 2024     Eden Research Plc ("Eden" or "Company")     Nematicide Approval in Greece   Eden Research plc (AIM: EDEN), a leader in sustainable...

Eden Research hails approval of biofungicide Mevalone in Germany

Eden Research PLC on Tuesday celebrated the grant of regulatory authorisation for use of its flagship biofungicide, M ...

Eden Research plc Biofungicide regulatory authorisation in Germany

Eden Research plc 13 August 2024   13 August 2024     Eden Research Plc ("Eden" or "Company")   Biofungicide regulatory authorisation in Germany   Eden Research plc (AIM: EDEN), the...

Eden Research plc Director/PDMR Shareholding

Eden Research plc 10 July 2024   10 July 2024     Eden Research plc ("Eden" or "the Company")   Director/PDMR Shareholding   Eden Research plc (AIM: EDEN), the AIM-quoted company focused on...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.38.333333333333.63.93.59829003.60262804DE
40.051.29870129873.854.153.54789983.66203635DE
12-0.35-8.235294117654.254.353.54042733.90129548DE
26-0.95-19.5876288664.854.93.53931634.13929388DE
52-0.95-19.5876288664.857.253.54196944.74986217DE
156-3.625-48.17275747517.525123.14022575.52036002DE
260-3.85-49.67741935487.7520.53.13413957.11399097DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
FARFerro-alloy Resources Limited
3.10p
(31.91%)
4.99M
RCGHRc365 Holding Plc
1.60p
(28.00%)
1.69M
CRTMCritical Metals Plc
1.20p
(20.00%)
493
STXShield Therapeutics Plc
3.15p
(17.76%)
16.93M
SEENSeeen Plc
4.00p
(11.11%)
20k
NTOGNostra Terra Oil And Gas Company Plc
0.02375p
(-36.67%)
403.18M
SLFRSlf Realisation Fund Limited
1.02p
(-27.66%)
80.35k
PPSProton Motor Power Systems Plc
0.14p
(-22.22%)
980.23k
QUIZQuiz Plc
4.12p
(-21.52%)
8.54k
PRMProteome Sciences Plc
2.30p
(-16.36%)
12.02k
NTOGNostra Terra Oil And Gas Company Plc
0.02375p
(-36.67%)
403.18M
NTVONativo Resources Plc
0.0023p
(0.00%)
232.35M
TRPTower Resources Plc
0.027p
(-1.82%)
100.02M
UKOGUk Oil & Gas Plc
0.02475p
(0.00%)
57.44M
SYNSynergia Energy Ltd
0.049p
(0.00%)
35.97M
Minddoc7 Minddoc7 3 minutos hace
https://www.ccn.com/news/crypto/coinbase-brian-armstrong-crypto-czar-charles-hoskinson/
COIN
Seminole Red Seminole Red 4 minutos hace
good job
cowtown jay cowtown jay 6 minutos hace
How much longer can it be before we start to see detailed stock quotes on this site (advfn) again? So many pieces of the puzzle are starting to be displayed, they have got to be near the point where they are snapped together. We've got to be generating revenue by now.
aniyahsbednar aniyahsbednar 8 minutos hace
Official Website... https://cutt.ly/qeKQMuOM

VitalRize Male Enhancement is a cutting-edge supplement designed to help men regain their stamina, boost testosterone levels, and improve overall confidence. With a blend of natural and clinically tested ingredients, VitalRize offers a holi
aniyahsbednar aniyahsbednar 22 minutos hace
Official Website... https://cutt.ly/2eKQSgxD

Green Regimen Energy and Focus is a dietary supplement designed to enhance energy levels and improve mental focus naturally. Crafted with clean, plant-based ingredients, it is often marketed as a solution for those looking to maintain peak
meshcan meshcan 22 minutos hace
Great investment in R&D. Nasrat has said they will only develop the big drugs who have $1B+ annual sale. So we should see our pipeline get better and better.
ELTP
MoneyMaker111 MoneyMaker111 23 minutos hace
GME to close at or above $30 todayyy?

$GME ( Hyper Bullish / Apish )
#GME ( Hyper Bullish / Apish )
GME
infamous infamous 25 minutos hace
thats funny. on otcmarkets they talk about affordable housing. thats a euphomism for cheap homes in getto areas. 100% sure on that description IMO
ATWT
Golfbum22 Golfbum22 44 minutos hace
Hey

Pauljon4

Your village people are calling

They are missing their anger management idiot

Please grow up and do your research before you think you are smarter than anyone here.

Show some respect and stop worrying about pric
FNMA
PC retired PC retired 44 minutos hace
"Entergy" is a real business, and a big one. All the supposed distributors use the name of a real world business with added or subtracted terms, purely intended to deceive. On another note, how is Mr Szilard's install doing?, we have not heard from him in quite a while- we demand an update!!
FLCX
NotSure2 NotSure2 45 minutos hace
Lol, a judge would not be waiting for approval or not of a company before rendering his/her/zer/their etc... judgment.

The worrying part is this:

Since KG is now (always been, deep state establishment) "an ennemy" of Donald Trump, KG now falls into "allie" of the democr
NWBO
DDA DDA 50 minutos hace
Some smaller amounts going through ... someone is silently pilling up
STGZ
The Danish Dude The Danish Dude 52 minutos hace
I have gone down the alley of dendritic cells and trying to look at alternatives for that time, for a dendritic cell vaccine, that in any way could align with the data in the clinical trial and the results and process covered in the article.

DocLee raises good questions. I have ping-p
NWBO
SkeBallLarry SkeBallLarry 54 minutos hace
Matthew Whitaker is a Great pick Steve Bannon sure is happy about it .. !!
The ELTP King The ELTP King 55 minutos hace
Nasrat promised "at least" two filings by the end of 2024 which means two positive BE studies.

Both BE studies failed.

Now he did say "at least" two filing so maybe the third BE study will actually pass?

Sure would be nice to get another BE or two up to t
ELTP
236T568 236T568 55 minutos hace
BREAKING:

Today’s launch by Russia of an intercontinental ballistic missile against Ukraine is the first time ever an ICBM has been launched at another state in a war.

https://x.com/visegrad24/status/1859515908172960221
TommyJ7651 TommyJ7651 55 minutos hace
I don't think asking Paul about future equity financings will yield much substance. It's not like the guy has a crystal ball and he can tell us exactly how future financing rounds will emerge or what situations we might find ourselves in. He will most likely tell us the same old story about them try
FFMGF
benz280e benz280e 57 minutos hace
Dung_Fart,

Who operates with self appointed importance.

Has spoken, all should take heed...
GDVM
The ELTP King The ELTP King 57 minutos hace
So not only is Nasrat hurting Elite with his Mikah nonsense, he's hurting Elite with his warrant nonsense as well.

The reason warrants are recorded as a liability because it shows the fair value loss the company is realizing during the fiscal period by issuing shares at current share
ELTP
The ELTP King The ELTP King 59 minutos hace
Do you have a learning disability?

They can't FREAKING buy ELTP because their brokerages don't allow it.

Tell everyone you know to tell 10 people to buy $100+ we can start a new MOASS like GME
ELTP GME

Su Consulta Reciente

Delayed Upgrade Clock